|
Follow Us:
Stories
Founders
Features
News
Startup / Scaleup
Events
Resources
Companies
Maps
About
Southeast Michigan Startup
NEI
Subscribe
Companies
Ann Arbor, MI 48104
FreeStride Therapeutics
FreeStride Therapeutics is working with Ohio State University to create a drug that relieves and even prevents shin pain for racing horses. It could also have implications for companion animals, like dogs and cats, suffering from arthritis. The Ann Arbor-based company, which is repurposing a human drug for veterinary purposes, has completed its first clinical trial and is raising seed capital to complete development.
Health Care
,
Higher Education
,
Research / Tech Transfer
Related Content
FreeStride Therapeutics scores win at Accelerate Michigan, adds positions
Friday, December 05, 2014
read on
Michigan Pre-Seed Capital Fund pumps $600K into 3 Ann Arbor-based start-ups
Friday, July 27, 2012
read on
FreeStride finishes clinical trial to explore veterinary applications for pain and arthritis drug
Friday, September 24, 2010
FreeStride Therapeutics is getting ready to hit its stride next year after it finishes laying the groundwork for what could turn out to be a long run in drug development.The Ann Arbor-based company, which is repurposing a human drug for veterinary purposes, has completed its first clinical trial and is raising seed capital to complete development. The start-up expects to raise $3.5-$4 million by year-end so it can seek FDA approval within three years. Thus far the
Michigan Pre-Seed Capital Fund
has provided funding for the founders to continue their research."It's all lab time," says Michael Long, who co-founded the three-person company a year-and-a half ago with David Olson and Noura Bashshur. "It's all about clinical trials and horses."
FreeStride Therapeutics
is working with Ohio State University to create a drug that relieves and even prevents shin pain for racing horses. It even has implications for companion animals, like dogs and cats, suffering from arthritis.
Source: Michael Long, co-founder and COO of FreeStride Therapeutics
Writer: Jon Zemke
read on
Sign up for our free monthly newsletter
A valid email address is required.
Invalid email format, please check email format.
Signup for
Email Alerts